About This Report
Introduction
This Report is the Environmental, Social and Governance Report issued by BGI Genomics Co., Ltd. (hereinafter referred to as "BGI Genomics" or the "Company") to its stakeholders. The Company has systematically reviewed and presented its key ESG management initiatives, progress, and performance in 2025, framed within the three dimensions of environment, society, and corporate governance. This Report illustrates the Company's approaches and achievements in implementing sustainability concepts in its daily operations and management activities. Through clearer and more traceable disclosure of responsibility information, the Company hopes to help all stakeholders fully understand its ESG practices and respond promptly to their concerns and expectations.
Reporting Period
This Report covers the period from January 1, 2025, to December 31, 2025. To enhance comparability, some content has been appropriately extended to previous and subsequent years.
Reporting Boundary
This Report is based on BGI Genomics Co., Ltd. as the main entity. Unless otherwise specified, the scope of this Report is consistent with the scope of the Company's consolidated financial statements for its 2025 annual report, covering the group's headquarters and its subordinate branches and subsidiaries.
Data Sources
The qualitative and quantitative information used in this Report is derived from BGI Genomics' official internal documents and annual reports. The data disclosed in this Report is sourced from the Company's actual operational raw data, publicly available government data, annual financial data, internal statistical reports, third-party surveys, and third-party evaluation interviews. The financial data in this Report is denominated in RMB. In case of any discrepancies with the Company's annual financial report, the annual financial report shall prevail.
Preparation Basis
United Nations Sustainable Development Goals (SDGs) Global Reporting Initiative (GRI) Standards Self-Regulatory Guidelines No. 2 for Listed Companies on Shenzhen Stock Exchange - Standardized Operation of Companies Listed on the ChiNext Market Self-Regulatory Guidelines No. 17 for Listed Companies on Shenzhen Stock Exchange - Sustainability Report (for Trial Implementation) Self-Regulatory Guidance No. 3 for Companies Listed on the ChiNext Market of Shenzhen Stock Exchange - Preparation of Sustainability Reports
Definitions
For ease of expression and reading, BGI Genomics Co., Ltd. is also referred to as "BGI Genomics", the "Company", or "we" in this Report.
How to Obtain the Report
This Report is available in electronic format. You can view it on the Company's website (https://www.bgi.com/) or on CNINFO (http://www.cninfo.com.cn). If you have any questions or suggestions regarding this Report, please send an email to info@genomics.cn or call +86-755-36307265.
2026: A New Journey of Integrity and Innovation - Safeguarding Public Health Through Genomics
Chairman Wang Jian
To all our partners, friends from all walks of life who care for and support BGI Genomics, and every investor:
The year 2025 was a year of transformation, building momentum, and steady quality improvement for BGI Genomics. We remained true to our original aspiration in scientific research, deepened our industrial application, and continuously solidified our foundation in technological innovation and global expansion, leveraging our proprietary technology platforms and core big data advantages to gather momentum for a new round of strategic upgrades. This confidence in our steady progress is inseparable from the valuable experience accumulated through the dedicated efforts of our past management teams, and even more so from the united and concerted efforts of all BGI employees and partners from all sectors.